Ansa Biotechnologies logo

Ansa Biotechnologies Funding & Investors

Berkeley, CA

Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.

https://ansabio.com/

Total Amount Raised: $83,419,680

Ansa Biotechnologies Funding Rounds

  • Series A

    $68,000,000

    Series A Investors

    Northpond Ventures
    Codon Capital
    Blue Water Life Science Fund
    Carbon/Silicon
    Mubadala Capital Ventures
    Horizons Ventures
    Fiscus Ventures
    Altitude Life Science Ventures
    PEAK6
    Fifty Years
    Ra Capital Management
    Humboldt Fund
    Mei Z.
  • Series Unknown

    $5,000,000

    Series Unknown Investors

    Horizons Ventures
    Humboldt Fund
    Mubadala Capital Ventures
  • Grant

    $994,682

    Grant Investors

    National Science Foundation (NSF)
  • Seed

    $7,900,000

    Seed Investors

    Horizons Ventures
    Mubadala Capital Ventures
    Humboldt Fund
    Y Combinator
  • Grant

    $225,000

    Grant Investors

    National Science Foundation (NSF)
  • Pre Seed

    $1,300,000

    Pre Seed Investors

    Fifty Years
Funding info provided by Diffbot.